New Target to Protect Vision Following Optic Nerve Trauma Discovered

In optic nerve injury condition, eliminating arginase 2 enzyme known to promote inflammation appears to aid recovery, reported scientists.

Enzyme arginase 2 could be used as the drug target to protect vision after optic nerve trauma, removing the enzyme, which increases with injury, decreases neuron death in the retina as well as the degeneration of nerve fibers that connect neurons to //each other and ultimately the brain, scientists report in the journal Frontiers in Neuroscience.

"Right now when an optic nerve crush injury happens, there is not a lot we can do to help the eye recover," says Dr. Ruth B. Caldwell, cell biologist in the Vascular Biology Center at the Medical College of Georgia at Augusta University.

Optic Neuritis-Causes-Symptoms-Signs-Treatment-Prevention-Complications
Optic neuritis is acute inflammation of the optic nerve. Optic nerve connects the eye to the brain and carries visual signals from the retina to the brain where it is received and interpreted.

‘For the first time, a link between brain derived neurotrophic factor and arginase 2 discovered. ’

"We know we can't prevent the initial damage, there is going to be some acute injury, but what deleting this enzyme seems to do is prevent subsequent amplification of the original injury. Collateral damage is less," says Caldwell, the study's corresponding author.

The findings elucidate both the role A2 plays in retinal damage following trauma and highlight A2's potential as a logical treatment target, the scientists write.

The optic nerves connect the eyes to the brain and collect impulses the retina generates from light so that we can see. There is currently no therapy that targets optic nerve trauma largely because understanding of all the damaging players is unclear, they write.

Vision can be Restored in Patients With Glaucoma and Optic Nerve Damage
Although vision loss leads to de-synchronization, these neural networks can be re-synchronized by ACS via rhythmic firing of the ganglion cells of the retina.

While little also is known about A2's normal function, it appears to be the polar opposite of arginase 1, an enzyme key to helping our liver eliminate ammonia. As the scientists recently found, A1 can suppress destructive inflammation that results when conditions like diabetes and glaucoma reduce blood flow to the retina. When A1 levels decrease, which they are finding happens in a variety of types of eye injuries, A2 levels increase and so do inflammation and damage.

In their model of optic nerve injury, they again found increased A2 expression after the injury and that neurons in the retina as well as retinal ganglion cells, the primary cell type in the optic nerve, began to die. While some death of retinal ganglion cells obviously occurs immediately following this type injury, destruction can continue out seven days or more, the scientists say.

Quiz on Eye Cancer
The eye is composed of several different types of tissues. Thus, cancer of the eye can be of a number of types. See how much you know about eye cancer by taking this quiz.

Higher A2 also increased glial cell activation following injury. Glial cells are a different type brain cell that nourish and otherwise support neurons. But when they are activated, they forgo their supportive role, Caldwell says.

The destructive results turned around, when they removed A2 from the equation. Neuron loss diminished as did the degeneration of nerve fibers, called axons that connect retinal ganglion cells to the brain, and glial activation was reduced. There were other signs of support, like an increase in brain derived neurotrophic factor, also known to support the survival of neurons and axons.

New Simulator Allows Patients to Experiment How Their Vision Will Improve Before Surgery
New technology developed by scientists helps cataract patients to gain a realistic impression of what their vision would be like with a multifocal lens.

They even saw some axons sprouting past the point of the crush injury, Fouda says.

"We have some evidence that possibly the axons are trying to repair themselves," Caldwell adds of these early indicators of the neurons' ability to reconnect with each other and ultimately the brain. "It looks like they are trying to get there," she says, "but we have a lot more work to do to prove that."

There also was more growth associated protein 43, or GAP43, which is known to help axons regenerate. In fact, the scientists found one way brain derived neurotrophic factor may benefit the optic nerve is by, in turn, helping increase the levels of GAP43. A2 deletion also inhibited injury associated-increases in inflammation-promoting immune cells like interleukin.

"We have already seen A2 go up in other types of injury," says Caldwell, referencing problems that also include retinal damage that occurs in premature babies as well as the ischemic retinopathy found in conditions like diabetes.

"What we know now is that when we delete A2, it makes recovery better from an optic nerve crush," Caldwell says.

To date in all their models, which now include optic nerve trauma, when A2 levels go up, A1 goes down.

They suspect that by giving a more stable but still human grade of A1, as they already are doing in other eye injury models, it will help drive down A2 in optic nerve crush injury as well, and are pursuing this and other lines of investigation.

Source-Eurekalert